Animal rights groups celebrate, but the Trump administration is light on specifics about phasing out federally funded medical testing on animals.
The push to abandon animal testing is gaining momentum, driven by the realization that it is costly, unreliable and ...
Brenner is a physician-scientist and president and chief executive officer of Sanford Burnham Prebys and lives in La Jolla. In 1937, there was great demand for a new way to treat streptococcal ...
Before a new drug can begin clinical trials in humans, it gets tested on animals. But things are changing. Late last year, Congress passed the FDA Modernization Act 2.0, which cleared the way for new ...
The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, science-forward drug development. By reducing reliance on animal models and ...
In a Policy Forum, Chad Nelson and colleagues highlight the efforts of the U.S. Food and Drug Administration (FDA) in advancing alternative methods to reduce animal testing for regulatory use. Animal ...
A rare moment of bipartisan progress has emerged with the Senate’s unanimous passage of the FDA Modernization Act 3.0, ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
There are a lot of hot-button questions when it comes to the ethics of scientific research, but the perennial issue of animal testing seems to incite fever-pitched anger on both side of the debate.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback